Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Retained Earnings (2016 - 2026)

Standard Biotools has reported Retained Earnings over the past 16 years, most recently at -$1.3 billion for Q4 2025.

  • Quarterly Retained Earnings fell 6.32% to -$1.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.3 billion through Dec 2025, down 6.32% year-over-year, with the annual reading at -$1.3 billion for FY2025, 6.32% down from the prior year.
  • Retained Earnings was -$1.3 billion for Q4 2025 at Standard Biotools, up from -$1.3 billion in the prior quarter.
  • Over five years, Retained Earnings peaked at -$284000.0 in Q2 2021 and troughed at -$1.3 billion in Q3 2025.
  • The 5-year median for Retained Earnings is -$890.5 million (2022), against an average of -$713.9 million.
  • The largest YoY upside for Retained Earnings was 99.95% in 2021 against a maximum downside of 657241.07% in 2021.
  • A 5-year view of Retained Earnings shows it stood at -$736.0 million in 2021, then fell by 25.83% to -$926.1 million in 2022, then decreased by 8.06% to -$1.0 billion in 2023, then fell by 18.48% to -$1.2 billion in 2024, then fell by 6.32% to -$1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for LAB's Retained Earnings are -$1.3 billion (Q4 2025), -$1.3 billion (Q3 2025), and -$1.2 billion (Q2 2025).